Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novozymes A/S Updates on Appointment of New President and Chief Executive Officer


Monday, 21 Jan 2013 01:50am EST 

Novozymes A/S announced that the Board of Directors has appointed Mr. Peder Holk Nielsen President and Chief Executive Officer (CEO) with effect from April 1, 2013. Mr. Nielsen will replace the current President and CEO, Mr. Steen Riisgaard, who after 12 years as CEO, and 33 years at Novozymes A/S and Novo Industri/Novo Nordisk steps down according to plan. Mr. Nielsen is currently Executive Vice President and Head of Enzyme Business, a position he has held since 2007. Mr. Nielsen’s career spans management positions within Novozymes A/S and Novo Industri/Novo Nordisk across business development, Research and Development, quality management, and sales and marketing. 

Company Quote

263.6
2.3 +0.88%
19 Dec 2014